Drug Discovery Biology

Uncovering the secrets of the human body

About us

Find out more about the Drug Discovery Biology theme.

Research labs

Our research groups are supported by government grant schemes and key industry partnerships, and collaborate extensively with national and international researchers.

Therapeutic areas

Learn about the five therapeutic areas that underpin the focus of our research.

PhD program

Discover what a higher degree with us entails and find out about available projects.

Research capabilities

Learn more about the techniques we employ.

Find a researcher

Build a collaboration



Contact us

For any enquiries please contact +61 3 9903 9614 or pharm-ddbenquiries@monash.edu.

Other research themes

See the latest news

Amylin-template peptides activate amylin receptors through distinct mechanism to calcitonin-template peptides. The image was created by Dr Sarah Piper.

Monash University researchers make a breakthrough discovery for development of new obesity treatments

World first: Researchers from Monash University have harnessed cutting-edge technology to fill key gaps in our understanding of how promising new therapeutics could work for the treatment of obesity.
25 March, 2022 Medicine & health

MIPS, partners, launch new centre of excellence for cryo-electron microscopy

Monash University, together with principal partners The University of Melbourne, University of Wollongong, WEHI, today launched the Australian Research Council’s Industrial Transformation Training Centre for Cryo-electron Microscopy of
4 February, 2022 Industry & partnerships
Septerna logo

Monash researchers founding scientists of new GPCR biotechnology company

Two researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) are amongst the co-founders of an exciting new biotechnology company dedicated to discovering and advancing novel small molecule medicines targeting G protein-coupled
1 February, 2022 Research

Monash scientists expose tumour-causing protein

Monash University scientists have discovered the structure of the protein behind neurofibromatosis type 1 (NF1), a common genetic condition that causes tumours to form on nerve tissue.
10 December, 2021 Medicine & health

Three MIPS researchers named in international Hi-Ci list

Professor Arthur Christopoulos, Professor Patrick Sexton and Associate Professor Denise Wootten are amongst the world’s most influential researchers, according to the 2021 iteration of the Clarivate Analytics Highly Cited Researchers list.
17 November, 2021

Monash launches new Neuromedicines Discovery Centre to transform treatments for mental health disorders

Monash University today will launch an end-to-end, cross-disciplinary Centre to drive novel psychiatric drug discovery, as well as new approaches to neuromedicine-assisted psychotherapies, for the treatment of mental health disorders.
10 November, 2021

MIPS researchers receive nearly $3.5M in NHMRC Ideas Grants

Funding through the Commonwealth Government’s National Health and Medical Research Council (NHMRC) has been announced, with the Monash Institute of Pharmaceutical Sciences (MIPS) successful in grants totalling close to $3.5 million.
4 November, 2021

“Sweet death”: Review highlights the dangers of high-fructose consumption

Monash University researcher and collaborator in the US published a review summarising recent studies on fructose and how high consumption of fructose leads to certain “lifestyle diseases”.
14 October, 2021

Monash University researchers paves way to the development of non-opioid painkillers to treat chronic pain

Monash University researchers have made a breakthrough discovery that could pave the way for the development of novel non-opioid painkillers (analgesics) to safely and effectively treat neuropathic pain.
9 September, 2021 Research